Anastasios Giakoumis

Dr. Anastasios Giakoumis


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2020 in European Journal of Haematology
Verified
Journal Article
Open access
PDF file
DFDimitrios Farmakis
Dimitrios Farmakis
AGAnastasios Giakoumis
Anastasios Giakoumis
MAMichael Angastiniotis
Michael Angastiniotis
AEAndroulla Eleftheriou
Androulla Eleftheriou
Therapeutic advances in β‐thalassaemia have gradually lead to a significant improvement in prognosis over the past few decades. As a result, patients living in areas where disease‐specific programmes offering access to modern therapy are in place experience a new era of prolonged survival that tends to reach that of the normal population. This ageing thalassaemia population, however, faces a new spectrum of comorbidities resulting from increasing age that may jeopardise the advances in prognosis provided by current therapy and thus poses new challenges in diagnosis, monitoring and treatment. In this position paper of the Thalassaemia International Federation, we review the changing epidemiology and clinical spectrum of patients with β‐thalassaemia and propose actions to be undertaken in order to address the emerging spectrum of comorbidities resulting from ageing.

1 January 2007 in Haematologica
Verified
Journal Article
Open access
PDF file
AAA. Aessopos
A. Aessopos
CFC. Fragodimitri
C. Fragodimitri
FKF. Karabatsos
F. Karabatsos
AHA. Hatziliami
A. Hatziliami
JYJ. Yousef
J. Yousef
MKM. Karagiorga
M. Karagiorga
Recent advances in magnetic resonance imaging (MRI) techniques allow the assessment of iron overload in tissues1 especially the heart,2 in transfusion- dependent thalassemia patients. The R2* value (1/T2*) recorded in the intraventricular septum of the heart indirectly measures the degree of cardiac iron load. Applying this new technology we looked at a number of historical and biochemical parameters in order to determine their relationship to cardiac iron overload and the effect of cardiac iron on functional and structural changes of the heart in transfusion-dependent thalassemics.

1 January 2003
Verified
Journal Article
Closed access
DFDimitrios Farmakis
Dimitrios Farmakis
AGAnastasios Giakoumis
Anastasios Giakoumis
EPEvaggelos Polymeropoulos
Evaggelos Polymeropoulos
AAAthanasios Aessopos
Athanasios Aessopos

23 June 2020 in European Journal of Haematology
Verified
Journal Article
Open access
PDF file
DFDimitrios Farmakis
Dimitrios Farmakis
AGAnastasios Giakoumis
Anastasios Giakoumis
LCLily Cannon
Lily Cannon
MAMichael Angastiniotis
Michael Angastiniotis
AEAndroulla Eleftheriou
Androulla Eleftheriou
Objectives Many patients with haemoglobinopathies, including thalassaemia and sickle cell disease, are at increased risk of developing severe complications from the coronavirus disease 2019 (COVID‐19). Although epidemiologic evidence concerning the novel coronavirus (SARS‐CoV‐2) infection in these patients is currently lacking, the COVID‐19 pandemic represents a significant challenge for haemoglobinopathy patients, their families and their attending physicians. Methods The present statement summarizes the key challenges concerning the management of haemoglobinopathies, with particular focus on patients with either transfusion‐dependent or non‐transfusion‐dependent thalassaemia, identifies the gaps in knowledge and suggests measures and strategies to deal with the pandemic, based on available evidence and expert opinions. Key areas covered include patients’ risk level, adaptation of haemoglobinopathy care, safety of blood transfusions, blood supply challenges, and lifestyle and nutritional considerations. Conclusions The proposed measures and strategies may be useful as a blueprint for other disorders which require regular hospital visits, as well as for the timely adaptation of patient care during similar future pandemics.

14 July 2007 in Cardiovascular Ultrasound
Verified
Journal Article
Open access
PDF file
AGAnastasios Giakoumis
Anastasios Giakoumis
VBVasilis Berdoukas
Vasilis Berdoukas
EGEfstathios Gotsis
Efstathios Gotsis
AAAthanassios Aessopos
Athanassios Aessopos
Background: Despite advances in survival in patients with thalassemia major (TM) the most common cause of death is cardiac disease. Regular cardiac follow-up is imperative in order to identify and reverse pathology. Cardiac Magnetic Resonance (CMR) and Echocardiography (US) are applied in parallel to TM patients for cardiac evaluation and ongoing monitoring. A comparison between mutual features would be useful in order to assess the accuracy and reliability of the two methods, with a particular focus on routine US application. TM's special attributes offer an excellent opportunity for cardiac imaging research that has universal general purpose applications. Methods: 135 TM patients underwent US (Teichholz's M-mode formula – rapidly accessible means of measuring volumes and ejection fraction) and CMR volumetry. Paired-samples t-test, Passing & Badlock regression and Bland & Altman plot were used while comparing the common parameters between the CMR and the US. Results: We found that the US volumes were underestimated, especially the end-diastolic volume (p < 0.001). The end-systolic volume showed a borderline two-tailed probability (p ≈ 0.05). The correlation for the ejection fraction was acceptable (r = 0.60) without a statistically significant difference (p = 0.37) and the Bland Altman plot range was narrow (25.8%). There was a satisfactory correlation of the US' shortening fraction with CMR's ejection fraction (r = 0.58). Conclusion: In cases where cardiac wall movement abnormalities are absent, the US Teichholz's M-mode formula for volume measurements, though less sophisticated in comparison to the high resolution CMR technique, offers an adequate ejection fraction estimation for routine use, especially when monitoring gross alterations in cardiac function over time, and is easy to perform.

22 November 2006 in European Journal of Haematology
Verified
Journal Article
Closed access
PDF file
AAAthanassios Aessopos
Athanassios Aessopos
AGAnastasios Giakoumis
Anastasios Giakoumis
CFChristina Fragodimitri
Christina Fragodimitri
FKFotis Karabatsos
Fotis Karabatsos
AHAntonia Hatziliami
Antonia Hatziliami
MKMarkissia Karagiorga
Markissia Karagiorga